Get your free personalized podcast brief

We scan new podcasts and send you the top 5 insights daily.

An acquisition should be a potential outcome, not the core strategy. Companies built with the intention of being sold often fail to play out satisfactorily. The most valuable companies are built with the conviction and operational mindset to become fully integrated, standalone entities.

Related Insights

Preparing a company for acquisition can lead founders to make short-term decisions that please the acquirer but undermine the brand's core agility, setting it up for failure post-sale. The focus shifts from longevity to a transaction.

Startups often fail to displace incumbents because they become successful 'point solutions' and get acquired. The harder path to a much larger outcome is to build the entire integrated stack from the start, but initially serve a simpler, down-market customer segment before moving up.

A powerful filter for any potential acquisition is asking: 'If this were the last business we could ever buy, would we still want to own it?' This simple question forces a long-term, operational mindset and helps avoid deals that rely on future exits or financial engineering.

Despite having sold multiple companies, founder Scott Davis's core philosophy is to build a business as if he will own it forever. He argues that focusing on an exit is a "perverse" mindset that distracts from the primary goal: providing genuine, sustainable value to customers, which is the ultimate driver of a company's worth.

Initial lowball acquisition offers can feel defeating, forcing a founder to abandon the exit dream. This forces a necessary shift to building a sustainable, long-term business. This new focus, ironically, is what makes the company far more attractive to acquirers in the future.

Instead of chasing trends or pivoting every few weeks, founders should focus on a singular mission that stems from their unique expertise and conviction. This approach builds durable, meaningful companies rather than simply chasing valuations.

Many founders focus on generating personal income, inadvertently creating a job they can't leave or sell. To build a true business asset, you must define an end goal (like a sale) from the beginning and structure operations, processes, and financials accordingly.

The paradox of long-term planning is that focusing on sustainability and succession—building a company that doesn't need an exit—makes it far more valuable and appealing to potential buyers. Robust, self-sufficient companies built to last are inherently better investments.

Viewing acquisitions as "consolidations" rather than "roll-ups" shifts focus from simply aggregating EBITDA to strategically integrating culture and operations. This builds a cohesive company that drives incremental organic growth—the true source of value—rather than just relying on multiple arbitrage from increased scale.

To achieve a high-value acquisition, biotechs must first build a credible strategy to succeed independently, creating a position of strength. Concurrently, leaders should keep multiple potential suitors proactively informed on all business aspects—not just clinical data—to facilitate a competitive bidding process when the time comes.